VITEK 2 AST-N447 TEST KIT Product reference 424620 Recall
VITEK 2 AST-N447 TEST KIT Product reference 424620
FDA recall Class II
Ongoing
FDA lists this Class II recall for VITEK 2 AST-N447 TEST KIT Product reference 424620. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2715-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jun 4, 2026
- FDA report date
- Jul 15, 2026
- Quantity in commerce
- 45,900 cards
- Distribution
- See key details
- FDA cause
- Process change control
What is being recalled?
VITEK 2 AST-N447 TEST KIT Product reference 424620
Affected model & UDI checker
Search the exact identifiers published for Z-2715-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | VITEK 2 AST-N447 TEST KIT Product reference 424620 | Check source notice | 03573026634551 |
FDA code information
Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.
Why was this product recalled?
Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did BIOMERIEUX, Inc. take?
Firm began notifying customers on June 4, 2026. Customers are instructed to dispose of pouches from the affected lot (Ref 424620, Lot 0853293604). Customer may choose to inspect each pouch in their inventory and only dispose of those with "P7" on the label, or they may choose to dispose of all cards from Lot 0853293604 in their inventory. Based on individual customer policy, customers may wish to perform retrospective review of resistant results. Customers should distribute the information to all appropriate personnel in their laboratory. If product was transferred or further distributed, customer should notify downstream users/accounts.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2715-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology